EGFR and congenital rubella syndrome: A previous report showed that T cells engineered with a broad-ErbB dimer targeting CAR, T1E28z, recognize both human and mouse ErbB+ cells and show dose-dependent side effects similar to CRS in mice when delivered intra-peritoneally (i.p.)42,43.